Background Cardiac surgery carries a heightened risk of bradyarrhythmias, but current permanent pacemaker (PPM) implantation ...
SEOUL, South Korea, April 16, 2025 /PRNewswire/ -- Mezzion Pharmaceuticals, a global leader in the development of therapies for patients with single ventricle heart disease, announces a transformative ...
AtaCor Medical announced today that it entered a financing worth up to $75 million to support its U.S. FDA pivotal study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback